Temporin-Las

General Information


DRACP ID  DRACP00405

Peptide Name   Temporin-Las

Sequence  LLRHVVKILSKYL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Temporins family

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW1116 Colon adenocarcinoma Carcinoma 62.73 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
SMMC-7721 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 59.37 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 56.81 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
Hep-G2 Hepatoblastoma; Hepatoblastoma Blastoma 55.98 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
BGC-823 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 50.85 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
A549 Lung adenocarcinoma Carcinoma 50.64 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
HL-7702(L-02) Human papillomavirus-related endocervical adenocarcinoma Carcinoma 37.00 Inhibition ratio at 50 µg/ml MTT assay 24 h 1
MEC Cholangiocarcinoma; Cholangiocarcinoma Carcinoma 27.99 Inhibition ratio at 50 µg/ml MTT assay 24 h 1

Hemolytic Activity  Showed no hemolytic activity against rabbit erythrocytes and human erythrocytes at 250 µg/ml

Normal (non-cancerous) Cytotoxicity  Showed little effects on the proliferation of the 293T human embryonic kidney cell line, MECs, and human lymphomonocytes at concentrations of less than 50 µg/ml

Target  Not available

Affinity  Not available

Mechanism  A membrane-disturbing action seems to be the major mechanism for cell death

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00405

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C76H132N20O16

Absent amino acids  ACDEFGMNPQTW

Common amino acids  L

Mass  179624

Pl  10.9

Basic residues  4

Acidic residues  0

Hydrophobic residues  7

Net charge  4

Boman Index  -154

Hydrophobicity  80.77

Aliphatic Index  194.62

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22641352

Title  Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain

Doi 10.1002/psc.2420

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.